BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 82 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $111,700,000 | +23.0% | 1,430,949 | 0.0% | 2.98% | +92.8% |
Q2 2018 | $90,837,000 | -27.6% | 1,430,949 | +4.6% | 1.55% | -30.1% |
Q1 2018 | $125,487,000 | +21.6% | 1,368,449 | 0.0% | 2.21% | +26.4% |
Q4 2017 | $103,195,000 | +147.3% | 1,368,449 | +128.5% | 1.75% | +154.3% |
Q3 2017 | $41,722,000 | +41.2% | 598,849 | +2.7% | 0.69% | +51.1% |
Q2 2017 | $29,553,000 | +0.8% | 583,245 | -20.5% | 0.46% | -19.9% |
Q1 2017 | $29,322,000 | +116.7% | 733,245 | +52.0% | 0.57% | +88.4% |
Q4 2016 | $13,533,000 | +167.1% | 482,455 | +182.8% | 0.30% | +193.2% |
Q3 2016 | $5,067,000 | +378.9% | 170,615 | +226.5% | 0.10% | +281.5% |
Q2 2016 | $1,058,000 | – | 52,250 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |